CN117045565A - 一种婴幼儿舒缓保湿面霜及其制备方法和应用 - Google Patents
一种婴幼儿舒缓保湿面霜及其制备方法和应用 Download PDFInfo
- Publication number
- CN117045565A CN117045565A CN202311314890.9A CN202311314890A CN117045565A CN 117045565 A CN117045565 A CN 117045565A CN 202311314890 A CN202311314890 A CN 202311314890A CN 117045565 A CN117045565 A CN 117045565A
- Authority
- CN
- China
- Prior art keywords
- component
- skin
- cream
- yolk oil
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 68
- 230000001815 facial effect Effects 0.000 title claims abstract description 40
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title abstract description 26
- 235000019198 oils Nutrition 0.000 claims abstract description 77
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 54
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 39
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 39
- 235000013345 egg yolk Nutrition 0.000 claims abstract description 39
- 239000002994 raw material Substances 0.000 claims abstract description 39
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000001816 cooling Methods 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000010438 heat treatment Methods 0.000 claims abstract description 18
- 229940059958 centella asiatica extract Drugs 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 16
- 235000020238 sunflower seed Nutrition 0.000 claims abstract description 16
- -1 glycerol glucoside Chemical class 0.000 claims abstract description 12
- 229930182478 glucoside Natural products 0.000 claims abstract description 9
- 206010013786 Dry skin Diseases 0.000 claims abstract description 8
- 230000037336 dry skin Effects 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims description 32
- 206010015150 Erythema Diseases 0.000 claims description 17
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 230000001804 emulsifying effect Effects 0.000 claims description 9
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 claims description 9
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 8
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 8
- 238000004945 emulsification Methods 0.000 claims description 8
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 8
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 7
- 235000013601 eggs Nutrition 0.000 claims description 7
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 7
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 7
- 229940101267 panthenol Drugs 0.000 claims description 7
- 235000020957 pantothenol Nutrition 0.000 claims description 7
- 239000011619 pantothenol Substances 0.000 claims description 7
- 229920002401 polyacrylamide Polymers 0.000 claims description 7
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 7
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 claims description 6
- 229940031674 laureth-7 Drugs 0.000 claims description 6
- 229940100460 peg-100 stearate Drugs 0.000 claims description 6
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 5
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 5
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 5
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 5
- 150000008131 glucosides Chemical class 0.000 claims description 5
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- 240000001548 Camellia japonica Species 0.000 claims description 4
- 235000018597 common camellia Nutrition 0.000 claims description 4
- 150000002009 diols Chemical class 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 3
- 150000001647 brassinosteroids Chemical class 0.000 claims description 3
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- 229940104261 taurate Drugs 0.000 claims description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 3
- 208000024891 symptom Diseases 0.000 claims description 2
- 206010040844 Skin exfoliation Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 19
- 239000000126 substance Substances 0.000 abstract description 4
- 239000003995 emulsifying agent Substances 0.000 abstract description 3
- 239000003906 humectant Substances 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 239000013589 supplement Substances 0.000 abstract description 3
- 239000002562 thickening agent Substances 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 125000004383 glucosinolate group Chemical group 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 38
- 230000000052 comparative effect Effects 0.000 description 19
- 230000002708 enhancing effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 5
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 2
- 230000036558 skin tension Effects 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 235000005637 Brassica campestris Nutrition 0.000 description 1
- 241001301148 Brassica rapa subsp. oleifera Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- MSJMDZAOKORVFC-UAIGNFCESA-L disodium maleate Chemical compound [Na+].[Na+].[O-]C(=O)\C=C/C([O-])=O MSJMDZAOKORVFC-UAIGNFCESA-L 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004692 intercellular junction Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
本发明提供了一种婴幼儿舒缓保湿面霜及其制备方法和应用,面霜的原料中添加了特殊方法制备得到的蛋黄油、向日葵籽油、积雪草提取物、甘油葡糖苷,还添加了一些保湿剂、乳化剂、增稠剂、皮肤调理剂等物质,其中,蛋黄油是由常温下的蛋黄油原料在短时间内降至低温,低温保存一段时间,然后再缓慢加热制备得到的,针对性处理过的蛋黄油和向日葵籽油对宝宝皮肤更温和,更亲肤,且能够改善泛红现象,减少婴儿肌肤水分流失,保持滋润度效果明显;甘油葡糖苷能够深层补水,使得婴幼儿脸部肌肤保持水嫩柔软;积雪草提取物也能舒缓婴幼儿肌肤的敏感,面霜能够改善婴幼儿脸部泛红现象,对干燥的皮肤有舒缓作用,能有效提高婴幼儿面部肌肤的滋润度。
Description
技术领域
本发明涉及了婴幼儿面霜技术领域,具体涉及了一种婴幼儿舒缓保湿面霜及其制备方法和应用。
背景技术
皮肤是人体最大的器官,作为人体和外部世界接触的表面,具有保护、排泄、调节体温和感受外界刺激等作用。日常生活中,面部皮肤常常受到紫外线、干燥、化学剂等各种内外因素的刺激,容易损伤,若不注意保养,皮肤状态将会变差,出现泛红、干燥缺水、皮肤粗糙等问题。
婴儿面部皮肤比成人皮肤更为娇嫩,皮肤较薄,皮脂膜发育不完全,容易受到外界的刺激引起干燥脱皮、泛红现象。为了保护婴儿肌肤不受损害,必须重视皮肤的日常护理。要真正养护肌肤,需要软化肌肤,促进角质细胞分化,改善细胞间连接,从而增强真皮的天然屏障作用,增强皮肤张力和弹性。
市场上的产品大多是为成年肌肤特点进行开发,不适用于婴儿这类特殊人群的面部皮肤,且市场上用于婴幼儿保湿的面霜,对泛红干燥的婴幼儿脸部缓解效果较差。
发明内容
本发明的目的在于:针对现有技术婴幼儿脸部面霜存在对泛红干燥的婴幼儿脸部缓解效果较差的问题,提供一种婴幼儿舒缓保湿面霜,该面霜能够改善婴幼儿脸部泛红现象,对干燥的皮肤有舒缓作用,能有效提高婴幼儿面部肌肤的滋润度,温和刺激性低,效果明显,便于推广。
为了实现上述目的,本发明采用的技术方案为:
一种婴幼儿舒缓保湿面霜,主要由以下重量百分比组分制成:
A组分:甘油3%~10%;
B组分:丙烯酰二甲基牛磺酸铵/VP 共聚物 0.3%~0.8%;泛醇 0.1%-0.5%;
C组分:鲸蜡硬脂醇 0.3%-1%;氢化聚异丁烯 1%-5%;辛酸/癸酸甘油三酯 3%-8%;甘油硬脂酸酯和/或PEG-100 硬脂酸酯 0.8%-1.5%;
D组分:聚丙烯酰胺、C13-14 异链烷烃及月桂醇聚醚-7中的至少一种 0.3%-1%;
E组分:蛋黄油 0.5%~1.5%;向日葵籽油0.5%~1.5%;积雪草提取物 0.05%-0.2%;甘油葡糖苷0.05%~0.1%;
余量水;
其中,所述蛋黄油是由常温下的蛋黄油原料在短时间内降至低温,低温保存一段时间,然后再缓慢加热制备得到的。
本发明提供了一种婴幼儿舒缓保湿面霜,面霜的原料中添加了特殊方法制备得到的蛋黄油、向日葵籽油、积雪草提取物、甘油葡糖苷,还添加了一些保湿剂、乳化剂、增稠剂、皮肤调理剂等物质,将各组分针对性的分组并调整了各组分的添加重量百分比,其中,蛋黄油是由常温下的蛋黄油原料在短时间内降至低温,低温保存一段时间,然后再缓慢加热制备得到的,针对性处理过的蛋黄油和向日葵籽油对宝宝皮肤更温和,更亲肤,且能够改善泛红现象,减少婴儿肌肤水分流失,保持滋润度效果明显;甘油葡糖苷能够深层补水,使得婴幼儿脸部肌肤保持水嫩柔软;积雪草提取物也能舒缓婴幼儿肌肤的敏感。在各个物质合理分组以及相互配合下,制备得到的面霜能够改善婴幼儿脸部泛红现象,对干燥的皮肤有舒缓作用,能有效提高婴幼儿面部肌肤的滋润度,温和刺激性低,软化肌肤,促进角质细胞分化,改善细胞间连接,从而增强真皮的天然屏障作用,增强皮肤张力和弹性,效果明显,便于推广应用。
进一步的,婴幼儿舒缓保湿面霜,主要由以下重量百分比组分制成:
A组分:甘油5%~10%;
B组分:丙烯酰二甲基牛磺酸铵/VP 共聚物 0.5%~0.8%;泛醇 0.2%-0.5%;
C组分:鲸蜡硬脂醇 0.5%-1%;氢化聚异丁烯 2%-5%;辛酸/癸酸甘油三酯 5%-8%;甘油硬脂酸酯和/或PEG-100 硬脂酸酯 1%-1.5%;
D组分:聚丙烯酰胺、C13-14 异链烷烃及月桂醇聚醚-7中的至少一种 0.5%-1%;
E组分:蛋黄油 0.8%~1.5%;向日葵籽油0.8%~1.5%;积雪草提取物 0.1%-0.2%;甘油葡糖苷0.06%~0.1%;
余量水。
发明人对面霜中原料添加比例做了优选设计,舒缓保湿效果更好。
进一步的,按原料组分重量百分比计,所述A组分中还包括透明质酸钠0.01%-0.05%;或/和,黄原胶0.02%-0.08%;所述B组分中还包括EDTA 二钠0.01%-0.05%。
优选地,按原料组分重量百分比计,所述A组分中还包括透明质酸钠0.03%-0.05%;或/和,黄原胶0.05%-0.08%;所述B组分中还包括EDTA 二钠0.03%-0.05%。
进一步的,按原料组分重量百分比计,所述C组分还包括山茶籽油0.05%-0.5%、鲸蜡硬脂基葡糖苷 0.2%-0.5%、生育酚乙酸酯 0.1%-0.5%、聚二甲基硅氧烷1%-2.5%、油菜甾醇类0.3%-1%中的至少一种。
进一步的,按原料组分重量百分比计,还包括F组分:对羟基苯乙酮0.4%-0.8%,以及二醇1%-5%、1,2-己二醇 0.4%-0.6%中的一种或两种。
进一步的,按原料组分重量百分比计,还包括G组分:CI 19140 0.0001%-0.0005%和CI 14700 0.00004%-0.00006%中的一种或两种。面霜内可适量添加着色剂。
进一步的,所述蛋黄油由以下方法制备得到的:
将常温蛋黄油原料在短时间内降温至-5℃~-20℃;然后缓慢加热至40℃~60℃,备用。
进一步的,所述蛋黄油由以下方法制备得到的:
将常温蛋黄油原料在30min~90min内降温至-5℃~-20℃,保持8~15h;然后在8h~15h内加热至40℃~60℃,备用。
经过发明人大量的实验研究发现,面霜中添加先快速低温保存再缓慢加热的蛋黄油,对皮肤缓解泛红,保湿有着显著的效果。
本发明的另一目的是为了提供上述婴幼儿舒缓保湿面霜的制备方法。
一种上述的婴幼儿舒缓保湿面霜的制备方法,包括以下步骤:
步骤1、将A组分物料、B组分物料以及水加入主锅中,搅拌加热至80℃~90℃,均质至完全溶解;
步骤2、将C组分物料和D组分物料同时加入主锅内,进行乳化、消泡处理,降温至40℃~50℃;
步骤3、向主锅内加入E组分物料,若有F组分或/和G组分一并加入,搅拌均匀,得到婴幼儿舒缓保湿面霜。
本申请提供的婴幼儿舒缓保湿面霜的制备过程,操作简单,便于推广实施。
进一步的,乳化处理过程中是在2500~3000 rpm条件下乳化5~8min;消泡处理采用抽真空的方式进行。
本发明的又一目的是为了提供上述婴幼儿舒缓保湿面霜的应用。
一种上述的面霜在缓解婴幼儿脸部干燥脱皮、泛红症状中的应用。
综上所述,由于采用了上述技术方案,本发明的有益效果是:
1、本发明提供了一种婴幼儿舒缓保湿面霜,面霜的原料中添加了特殊方法制备得到的蛋黄油、向日葵籽油、积雪草提取物、甘油葡糖苷,还添加了一些保湿剂、乳化剂、增稠剂、皮肤调理剂等物质,将各组分针对性的分组并调整了各组分的添加重量百分比,其中,蛋黄油是由常温下的蛋黄油原料在短时间内降至低温,低温保存一段时间,然后再缓慢加热制备得到的,针对性处理过的蛋黄油和向日葵籽油对宝宝皮肤更温和,更亲肤,且能够改善泛红现象,减少婴儿肌肤水分流失,保持滋润度效果明显;甘油葡糖苷能够深层补水,使得婴幼儿脸部肌肤保持水嫩柔软;积雪草提取物也能舒缓婴幼儿肌肤的敏感。在各个物质合理分组以及相互配合下,制备得到的面霜一周内能够消除婴幼儿脸部泛红现象,使得干燥的皮肤变的水嫩光滑,两周内能有效提高婴幼儿面部肌肤的滋润度,泛红情况彻底消失,温和刺激性低,效果明显,便于推广应用。
2、本申请提供的婴幼儿舒缓保湿面霜的制备过程,操作简单,便于推广实施。
3、本申请提供了面霜在缓解婴幼儿脸部干燥脱皮、泛红症状中的应用。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅用以解释本发明,并不用于限定本发明。
以下实施例及对比例中,所用部分原料的规格来源如下:
常温蛋黄油:产地,广州;品牌,广州晶晶;CAS,8001-17-0;外观,金黄色油状液体。
甘油:青岛醇兴化工有限公司,CAS,76-85-22;密度,1.2633(g/cm3)。
鲸蜡硬脂醇:上海雅程化工有限公司,CAS,67762-27-0;密度,0.82(g/cm3)。
积雪草提取物:陕西纽芙生物科技有限公司。
甘油葡糖苷:山西乐鸿生物科技有限公司,型号,GYPTG。
实施例1
原料准备(按重量百分比计)
制备蛋黄油:
将常温蛋黄油原料在60min内降温至-10℃,保持10h;然后在12h内加热至50℃,备用。
A组分:甘油5%;明质酸钠0.03%;黄原胶0.05%。
B组分:丙烯酰二甲基牛磺酸铵/VP 共聚物 0.5%;泛醇0.3%; EDTA 二钠0.03%。
C组分:鲸蜡硬脂醇 0.5%;氢化聚异丁烯 3%;辛酸/癸酸甘油三酯 5%;甘油硬脂酸酯和PEG-100 硬脂酸酯 1.0%;山茶籽油0.3%、鲸蜡硬脂基葡糖苷0.3%、生育酚乙酸酯0.3%、聚二甲基硅氧烷1.5%、油菜甾醇类0.5%。
D组分:聚丙烯酰胺0.2%、C13-14 异链烷烃0.2%及月桂醇聚醚-7 0.2%;
E组分:蛋黄油 1.0%;向日葵籽油1.0%;积雪草提取物 0.1%;甘油葡糖苷0.08%;
F组分:对羟基苯乙酮0.5%,以及二醇3%、1,2-己二醇 0.5%。
G组分:CI 19140为 0.0003%、CI 14700 为0.00005%。
余量水。
制备面霜
步骤1、将A组分物料、B组分物料以及水加入主锅中,搅拌加热至85℃,均质至完全溶解;
步骤2、将C组分物料和D组分物料同时加入主锅内,进行乳化、消泡处理,降温至45℃;乳化处理过程中是在2800 rpm条件下乳化6min;消泡处理采用抽真空的方式进行;
步骤3、向主锅内加入E组分、F组分和G组分物料,搅拌均匀,得到婴幼儿舒缓保湿面霜。
实施例2
原料准备(按重量百分比计)
制备蛋黄油:
将常温蛋黄油原料在90min内降温至-5℃,保持15h;然后在15h内加热至60℃,备用。
A组分:甘油10%;明质酸钠0.05%。
B组分:丙烯酰二甲基牛磺酸铵/VP 共聚物 0.8%;泛醇 0.5%; EDTA 二钠0.05%。
C组分:鲸蜡硬脂醇 1%;氢化聚异丁烯 5%;辛酸/癸酸甘油三酯 8%;甘油硬脂酸酯和PEG-100 硬脂酸酯1.5%;鲸蜡硬脂基葡糖苷 0.5%、生育酚乙酸酯 0.5%、聚二甲基硅氧烷2.5%、油菜甾醇类1%。
D组分:聚丙烯酰胺0.3%、C13-14 异链烷烃0.3%及月桂醇聚醚-7为0.3%;
E组分:蛋黄油 1.5%;向日葵籽油1.5%;积雪草提取物0.2%;甘油葡糖苷0.1%;
F组分:二醇5%、1,2-己二醇 0.6%。
G组分:CI 19140 0.0005%。
余量水。
制备面霜
步骤1、将A组分物料、B组分物料以及水加入主锅中,搅拌加热至90℃,均质至完全溶解;
步骤2、将C组分物料和D组分物料同时加入主锅内,进行乳化、消泡处理,降温至50℃;乳化处理过程中是在3000 rpm条件下乳化8min;消泡处理采用抽真空的方式进行;
步骤3、向主锅内加入E组分、F组分和G组分物料,搅拌均匀,得到婴幼儿舒缓保湿面霜。
实施例3
原料准备(按重量百分比计)
制备蛋黄油:
将常温蛋黄油原料在30min内降温至-20℃,保持8h;然后在8h内加热至40℃,备用。
A组分:甘油3%;黄原胶0.02%。
B组分:丙烯酰二甲基牛磺酸铵/VP 共聚物 0.3%;泛醇 00.1%;
C组分:鲸蜡硬脂醇 0.3%;氢化聚异丁烯 1%;辛酸/癸酸甘油三酯 3%;甘油硬脂酸酯0.8%;山茶籽油0.05%、鲸蜡硬脂基葡糖苷 0.2%、生育酚乙酸酯 0.1%、聚二甲基硅氧烷1%。
D组分:聚丙烯酰胺0.1%、C13-14 异链烷烃0.1%及月桂醇聚醚-7为0.1%;
E组分:蛋黄油 0.5%;向日葵籽油0.5%;积雪草提取物 0.05%;甘油葡糖苷0.05%;
F组分:对羟基苯乙酮0.4%, 1,2-己二醇 0.4%。
G组分: CI 14700 0.00004%。
余量水。
制备面霜
步骤1、将A组分物料、B组分物料以及水加入主锅中,搅拌加热至80℃,均质至完全溶解;
步骤2、将C组分物料和D组分物料同时加入主锅内,进行乳化、消泡处理,降温至40℃;乳化处理过程中是在2500 rpm条件下乳化5min;消泡处理采用抽真空的方式进行;
步骤3、向主锅内加入E组分、F组分和G组分物料,搅拌均匀,得到婴幼儿舒缓保湿面霜。
实施例4
原料准备(按重量百分比计)
制备蛋黄油:
将常温蛋黄油原料在60min内降温至-10℃,保持10h;然后在10h内加热至50℃,备用。
A组分:甘油6%;
B组分:丙烯酰二甲基牛磺酸铵/VP 共聚物 0.45%;泛醇 0.25%;
C组分:鲸蜡硬脂醇0.55%;氢化聚异丁烯 0.3%;辛酸/癸酸甘油三酯 4%;PEG-100硬脂酸酯0.9%;
D组分:聚丙烯酰胺0.2%、C13-14 异链烷烃0.2%及月桂醇聚醚-7为0.2%;
E组分:蛋黄油 0.8%;向日葵籽油1.2%;积雪草提取物 0.1%;甘油葡糖苷0.07%;
余量水。
制备面霜
步骤1、将A组分物料、B组分物料以及水加入主锅中,搅拌加热至82℃,均质至完全溶解;
步骤2、将C组分物料和D组分物料同时加入主锅内,进行乳化、消泡处理,降温至45℃;乳化处理过程中是在3000 rpm条件下乳化8min;消泡处理采用抽真空的方式进行;
步骤3、向主锅内加入E组分物料,搅拌均匀,得到婴幼儿舒缓保湿面霜。
对比例1
对比例1制备的面霜相比实施例1,未添加蛋黄油,向日葵籽油的添加百分比调整为2%,其余的原料种类、添加百分比以及面霜制备过程都与实施例1相同。
对比例2
对比例2制备的面霜相比实施例1,未添加向日葵籽油,蛋黄油的添加百分比调整为2%,其余的原料种类、添加百分比以及面霜制备过程都与实施例1相同。
对比例3
对比例3制备的面霜相比实施例1,未添加积雪草提取物,甘油葡糖苷的添加百分比调整为0.18%,其余的原料种类、添加百分比以及面霜制备过程都与实施例1相同。
对比例4
对比例4制备的面霜相比实施例1,未添加甘油葡糖苷,积雪草提取物的添加百分比调整为0.18%,其余的原料种类、添加百分比以及面霜制备过程都与实施例1相同。
对比例5
对比例5制备的面霜相比实施例1,将蛋黄油换成直接购买的常温蛋黄油,其余的原料种类、添加百分比以及面霜制备过程都与实施例1相同。
对比例6
对比例6制备的面霜相比实施例1,改变了蛋黄油的制备过程,其余的原料种类、添加百分比以及面霜制备过程都与实施例1相同。
具体的蛋黄油的制备过程如下:
将常温蛋黄油原料在5h内降温至-10℃,保持10h;然后在12h内加热至50℃,备用。
对比例7
对比例7制备的面霜相比实施例1,改变了蛋黄油的制备过程,其余的原料种类、添加百分比以及面霜制备过程都与实施例1相同。
具体的蛋黄油的制备过程如下:
将常温蛋黄油原料在20min内降温至-10℃,保持10h;然后在1h内加热至50℃,备用。
测试
寻找110名10个月~6周岁的脸部明显泛红且脸部皮肤干燥、粗糙的婴幼儿为试验对象,将110名婴幼儿分为11组,每组10名小朋友,11组小朋友在性别,年龄,脸部情况等分组上具有统计学意义。
11组小朋友分别使用实施例1-4以及对比例1-7制备的面霜进行脸部护理,每天早晚使用各一次,连续使用一周,记录小朋友脸部泛红恢复情况,以及小朋友脸部干燥情况。然后继续连续使用一周,记录小朋友脸部泛红情况,以及小朋友脸部保湿情况,具体的记录结果如表1所示。
利用皮肤角质层水分含量测量仪Corneomer对每组试验小朋友脸部用面霜前以及使用面霜两周后,平均含水量提升率(%),具体测试结果如表1所示,含水量提升越高,说明小朋友脸部滋润度越高。
表1
从表1的测试结果可以看出,实施例1-4采用本申请提供的一种婴幼儿舒缓保湿面霜的原料配方和制备方法,制备得到的面霜一周内能够消除婴幼儿脸部泛红现象,使得干燥的皮肤变的水嫩光滑,两周内能有效提高婴幼儿面部肌肤的滋润度,泛红情况彻底消失,温和刺激性低,效果明显。对比例1-4制备的面霜相对实施例1依次缺少了特殊方法制备得到的蛋黄油、向日葵籽油、积雪草提取物、甘油葡糖苷,面霜对改善婴幼儿脸部泛红以及皮肤干燥的效果有了明显的下降。对比例5将本申请的蛋黄油替换成直接购买得到的常规蛋黄油,制备的面霜对改善婴幼儿脸部泛红以及皮肤干燥的效果有了明显的下降,见效时长明显延缓。对比例6和对比例7改变了蛋黄油的制备过程,制备出来的蛋黄油用于制备面霜,效果明显下降。
本申请提供的面霜在各个物质合理分组以及相互配合下,制备得到的面霜能够改善婴幼儿脸部泛红现象,对干燥的皮肤有舒缓作用,能有效提高婴幼儿面部肌肤的滋润度,温和刺激性低,软化肌肤,促进角质细胞分化,改善细胞间连接,从而增强真皮的天然屏障作用,增强皮肤张力和弹性,效果明显,便于推广应用。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.一种婴幼儿舒缓保湿面霜,其特征在于,主要由以下重量百分比组分制成:
A组分:甘油3%~10%;
B组分:丙烯酰二甲基牛磺酸铵/VP 共聚物 0.3%~0.8%;泛醇 0.1%-0.5%;
C组分:鲸蜡硬脂醇 0.3%-1%;氢化聚异丁烯 1%-5%;辛酸/癸酸甘油三酯 3%-8%;甘油硬脂酸酯和/或PEG-100 硬脂酸酯 0.8%-1.5%;
D组分:聚丙烯酰胺、C13-14 异链烷烃及月桂醇聚醚-7中的至少一种 0.3%-1%;
E组分:蛋黄油 0.5%~1.5%;向日葵籽油0.5%~1.5%;积雪草提取物 0.05%-0.2%;甘油葡糖苷0.05%~0.1%;
余量水;
其中,所述蛋黄油是由常温下的蛋黄油原料在短时间内降至低温,低温保存一段时间,然后再缓慢加热制备得到的。
2. 根据权利要求1所述的婴幼儿舒缓保湿面霜,其特征在于,按原料组分重量百分比计,所述A组分中还包括透明质酸钠0.01%-0.05%;或/和,黄原胶0.02%-0.08%;所述B组分中还包括EDTA 二钠0.01%-0.05%。
3.根据权利要求1所述的婴幼儿舒缓保湿面霜,其特征在于,按原料组分重量百分比计,所述C组分还包括山茶籽油0.05%-0.5%、鲸蜡硬脂基葡糖苷 0.2%-0.5%、生育酚乙酸酯0.1%-0.5%、聚二甲基硅氧烷1%-2.5%、油菜甾醇类0.3%-1%中的至少一种。
4.根据权利要求1所述的婴幼儿舒缓保湿面霜,其特征在于,按原料组分重量百分比计,还包括F组分:对羟基苯乙酮0.4%-0.8%,以及二醇1%-5%、1,2-己二醇 0.4%-0.6%中的一种或两种。
5.根据权利要求1所述的婴幼儿舒缓保湿面霜,其特征在于,按原料组分重量百分比计,还包括G组分:CI 19140 0.0001%-0.0005%和CI 14700 0.00004%-0.00006%中的一种或两种。
6.根据权利要求1-5任意一项所述的婴幼儿舒缓保湿面霜,其特征在于,所述蛋黄油由以下方法制备得到的:
将常温蛋黄油原料在短时间内降温至-5℃~-20℃,保持一段时间;然后缓慢加热至40℃~60℃,备用。
7.根据权利要求6所述的婴幼儿舒缓保湿面霜,其特征在于,所述蛋黄油由以下方法制备得到的:
将常温蛋黄油原料在30min~90min内降温至-5℃~-20℃,保持8~15h;然后在8h~15h内加热至40℃~60℃,备用。
8.一种如权利要求1-7任意一项所述的婴幼儿舒缓保湿面霜的制备方法,其特征在于,包括以下步骤:
步骤1、将A组分物料、B组分物料以及水加入主锅中,搅拌加热至80℃~90℃,均质至完全溶解;
步骤2、将C组分物料和D组分物料同时加入主锅内,进行乳化、消泡处理,降温至40℃~50℃;
步骤3、向主锅内加入E组分物料,若有F组分或/和G组分一并加入,搅拌均匀,得到婴幼儿舒缓保湿面霜。
9. 根据权利要求8所述的婴幼儿舒缓保湿面霜的制备方法,其特征在于,乳化处理过程中是在2500~3000 rpm条件下乳化5~8min;消泡处理采用抽真空的方式进行。
10.一种如权利要求1-7任意一项所述的面霜在缓解婴幼儿脸部干燥脱皮、泛红症状中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311314890.9A CN117045565A (zh) | 2023-10-12 | 2023-10-12 | 一种婴幼儿舒缓保湿面霜及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311314890.9A CN117045565A (zh) | 2023-10-12 | 2023-10-12 | 一种婴幼儿舒缓保湿面霜及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117045565A true CN117045565A (zh) | 2023-11-14 |
Family
ID=88653960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311314890.9A Pending CN117045565A (zh) | 2023-10-12 | 2023-10-12 | 一种婴幼儿舒缓保湿面霜及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117045565A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110393691A (zh) * | 2019-09-01 | 2019-11-01 | 福建省梦娇兰日用化学品有限公司 | 一种含天然植物的婴幼儿抗敏保湿霜 |
CN112641712A (zh) * | 2021-01-14 | 2021-04-13 | 铂臻(广州)生物科技有限公司 | 一种具有修复过敏性肌肤功效的组合物、面霜及制备方法 |
CN115300446A (zh) * | 2022-10-10 | 2022-11-08 | 金发拉比妇婴童用品股份有限公司 | 一种蛋黄油组合物及其制备方法与应用 |
CN116473903A (zh) * | 2023-05-05 | 2023-07-25 | 上海中翊日化有限公司 | 一种保湿舒缓修护的高功效婴童护肤精华液及制备方法 |
-
2023
- 2023-10-12 CN CN202311314890.9A patent/CN117045565A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110393691A (zh) * | 2019-09-01 | 2019-11-01 | 福建省梦娇兰日用化学品有限公司 | 一种含天然植物的婴幼儿抗敏保湿霜 |
CN112641712A (zh) * | 2021-01-14 | 2021-04-13 | 铂臻(广州)生物科技有限公司 | 一种具有修复过敏性肌肤功效的组合物、面霜及制备方法 |
CN115300446A (zh) * | 2022-10-10 | 2022-11-08 | 金发拉比妇婴童用品股份有限公司 | 一种蛋黄油组合物及其制备方法与应用 |
CN116473903A (zh) * | 2023-05-05 | 2023-07-25 | 上海中翊日化有限公司 | 一种保湿舒缓修护的高功效婴童护肤精华液及制备方法 |
Non-Patent Citations (1)
Title |
---|
广州市赞盛商贸有限公司: "乖比比婴儿驼奶滋润霜", pages 1 - 2, Retrieved from the Internet <URL:https://hzpba.nmpa.gov.cn/gccx/chakanHis.html?prodId=20200730143055k4u07&gb=G> * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111053703B (zh) | 用于婴幼儿皮肤屏障守护的分段健脂护肤组合物 | |
CN111481475A (zh) | 一种改善女性荷尔蒙的可食性唇膏及其制备方法 | |
CN111150686A (zh) | 一种肌初赋活多肽-角鲨烷鲜活按摩眼霜 | |
CN111346024A (zh) | 一种面部去角质磨砂膏及其制备方法 | |
CN112263528A (zh) | 一种胶原蛋白果冻面膜及其制备和使用方法 | |
CN114796024B (zh) | 用于皮肤屏障修复的仿生皮脂组合物及其制备方法和应用 | |
CN112245315A (zh) | 一种具有保湿修复功效的神经酰胺面膜及其制备方法 | |
CN114712275A (zh) | 一种抗皱修复组合物及其制备方法、化妆品及其制备方法 | |
CN112190518A (zh) | 一种美白保湿面膜及其制备方法 | |
CN111671692A (zh) | 一种祛痘组合物及其制备方法与应用 | |
CN107970140A (zh) | 一种含有鳄鱼油的祛疤组合物及其应用 | |
CN110801411A (zh) | 一种保湿补水美白乳液及其制备方法 | |
CN111434332A (zh) | 滋养修护乳液及其制备方法 | |
CN112716842A (zh) | 一种具有长效保湿效果的有机保湿霜及其制备方法 | |
CN109620758B (zh) | 一种双层头皮护理组合物及其制备方法 | |
CN117045565A (zh) | 一种婴幼儿舒缓保湿面霜及其制备方法和应用 | |
CN107955756B (zh) | 一种手工皂及其制备方法 | |
CN113425642B (zh) | 一种眼部护理组合物 | |
CN112370404B (zh) | 一种保湿美白组合物、其制备方法及应用 | |
CN113876671A (zh) | 一种含油菜芽提取物的抗衰老组合物及其制备方法 | |
CN113768803A (zh) | 一种防脱发去屑喷剂的组合物及制备方法 | |
CN111920727A (zh) | 一种消炎排毒的身体泥膜及其制备方法 | |
CN112089677A (zh) | 一种保湿美白的护肤珍珠水及其制备方法 | |
CN111840199A (zh) | 一种蜂蜜面膜及其制备方法 | |
CN114129478B (zh) | 硬壳桂提取物在洗发水中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20231114 |